chronic lymphocytic leukemia

Clinical Images

Electro-Anatomically-Guided Endomyocardial Biopsy in a Patient With Focal Myocardial Infiltration and Chronic Lymphocytic Leukemia

02/15/2024

Maciej T. Wybraniec, MD, PhD^1,2,3; Marek Grabka, MD, PhD¹; Andrzej Hoffmann, MD, PhD¹; Romuald Wojnicz, MD, PhD⁴; Katarzyna Mizia-Stec, MD, PhD^1,2,3

Maciej T. Wybraniec, MD, PhD1,2,3; Ma...

A 53-year-old female was admitted to the cardiology department on account of signs and symptoms of congestive heart failure with severe peripheral edema and dyspnea on exertion (New York Heart Association class III) for the past 3 months.

A 53-year-old female was...

02/15/2024

Journal of Invasive Cardiology

Research Reports

The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences

06/21/2022

Matthew S Davids MD, MMSC

Beenish S Manzoor, PhD, MPH

Nisha C Hazra, PhD, MSc

Honghao Fang, MSc

Arliene Ravelo, MPH

Fang Han

Annie Guerin, MS

Kavita Sail, PhD

Sheila Shapouri, MS

Mazyar Shadman, MD, MPH

Dr Davids and colleagues estimated the total cumulative costs per patient of treatment sequences for adults with chronic lymphocytic leukemia, with and without deletion 17p, as well as the budget impact of introducing sequences with...

Dr Davids and colleagues...

06/21/2022

Journal of Clinical Pathways

News

Acalabrutinib Improves PFS and OS Over Other First-Line Regimens in CLL

02/16/2021

Journal of Clinical Pathways

Conference Coverage

Real-World Toxicity and Tolerability of Ibrutinib for CLL or SLL

12/09/2020

Journal of Clinical Pathways

Conference Coverage

Ibrutinib Dose Reductions and Discontinuations for CLL in Routine Practice vs Clinical Trials

12/04/2020

Journal of Clinical Pathways

Interview

Novel Ibrutinib Combination for Primary Treatment of CLL

06/22/2020

On April 21, 2020, the FDA expanded its approval of ibrutinib to include its use in combination with rituximab for the primary treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma...

On...

06/22/2020

Journal of Clinical Pathways

Understanding New Treatments for Chronic Lymphocytic Leukemia

04/04/2016

JCP Editors

Recent Food and Drug Administration (FDA) approvals have changed the landscape of treatment for chronic lymphocytic leukemia (CLL). In a session at the 2016 National Comprehensive Cancer Network (NCCN) Annual...

Recent...

04/04/2016

Journal of Clinical Pathways